Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

NCT00322842

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University of Cologne Cologne, Germany

Carl Gustav Carus University Hospital Dresden, Germany

University of Heidelberg Heidelberg, Germany

View Trial Details

Completed

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00328198

Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL), Bronchial Diseases, Bronchiolitis, +25 more
Locations: Moores Cancer Center La Jolla, California, United States

Wilshire Oncology Medical Group La Verne, California, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States

Rocky Mountain Cancer Centers Colorado Springs, Colorado, United States

View all 21 locations

View Trial Details

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

NCT00103662

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: City of Hope Samaritan Bone Marrow Transplant Program Phoenix, Arizona, United States

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope National Medical Center Duarte, California, United States

Cedars-Sinai Los Angeles, California, United States

View all 39 locations

View Trial Details

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

NCT00103610

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: City of Hope Samaritan Bone Marrow Transplant Program Phoenix, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

Yale University School of Medicine New Haven, Connecticut, United States

View all 32 locations

View Trial Details

Completed

Thalidomide to Patients With Previously Untreated Multiple Myeloma

NCT00218855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department of Haematology, St. Olavs hospital/NTNU Trondheim, Norway

View Trial Details

Completed

AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

NCT00396266

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Tom Baker Cancer Center Calgary, Alberta, Canada

Vancouver General Hospital, BC Cancer Agency Vancouver, British Columbia, Canada

View Trial Details

Completed

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004145

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

NCT00791011

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: Not specified

View Trial Details

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

NCT00538850

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
Locations: InSys Therapeutics, Incorporated Chandler, Arizona, United States

View Trial Details

Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Institute of Medical and Veterinary Science Adelaide, South Australia, Australia

Royal Melbourne Hospital Parkville, Victoria, Australia

Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada

View all 16 locations

View Trial Details